المؤلفون: Erminia Ridolo, Alessandro Barone, Martina Ottoni, Silvia Peveri, Marcello Montagni, Francesca Nicoletta

المصدر: International Journal of Molecular Sciences, Vol 25, Iss 3, p 1702 (2024)

مصطلحات موضوعية: biological drugs, benralizumab, cendakimab, dupilumab, eosinophilic esophagitis, lirentelimab mepolizumab, Biology (General), QH301-705.5, Chemistry, QD1-999

Relation: https://www.mdpi.com/1422-0067/25/3/1702; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067; https://doaj.org/article/2a4ea6bb9ed54470b0df5678d049a47c

الاتاحة: https://doi.org/10.3390/ijms25031702
https://doaj.org/article/2a4ea6bb9ed54470b0df5678d049a47c

المؤلفون: Ridolo E., Barone A., Ottoni M., Peveri S., Montagni M., Nicoletta F.

المساهمون: Ridolo, E., Barone, A., Ottoni, M., Peveri, S., Montagni, M., Nicoletta, F.

مصطلحات موضوعية: benralizumab, biological drug, cendakimab, dupilumab, eosinophilic esophagiti, lirentelimab mepolizumab, monoclonal antibodie, reslizumab, tezepelumab

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:001160153000001; volume:25; issue:3; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/11381/2997113; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85184472220

الاتاحة: https://hdl.handle.net/11381/2997113
https://doi.org/10.3390/ijms25031702